Supernus Pharmaceuticals

Supernus Pharmaceuticals, Inc. is a pharmaceutical company based in Rockville, Maryland, founded in 2005. The company specializes in developing and commercializing products for central nervous system (CNS) diseases. Supernus focuses on conditions such as epilepsy, migraine, attention deficit hyperactivity disorder (ADHD), and rare diseases. The company offers several FDA-approved medications, including Oxtellar XR for epilepsy, Trokendi XR for epilepsy and migraine prevention, Qelbree for pediatric and adult ADHD, and Sumavel DosePro for rare diseases. Supernus has expanded its capabilities through strategic acquisitions, including Biotie Therapies Corp. in 2024. Under the leadership of President and CEO Jack Khattar, Supernus Pharmaceuticals is dedicated to addressing unmet medical needs in neurology and psychiatry, serving healthcare providers, neurologists, psychiatrists, and patients.

Pharmaceuticals Rockville, United States Founded 2005 ~686 employees NASDAQ: SUPN

Work at Supernus Pharmaceuticals in HR or recruiting? Claim this page

Employees
686
+2.2% in the 3 months to Jun 2025
Revenue / employee
$974K
Revenue ~$668M
Stock
SUPN
NASDAQ
12-month attrition
7.9%
Tech: 3.6%
H1B sponsor
NA

Headcount trend

Supernus Pharmaceuticals went from 637 employees in Jul 2023 to 686 in Jun 2025. Jan to Jun 2025: 28 people joined, 14 left.

Headcount data through Jun 2025

Org structure

Headcount by department

Sales327
Other260
Operations39
Finance19
Marketing13
HR13
Engineering13
Product1

Executive compensation

Hiring now

See all jobs

Supernus Pharmaceuticals FAQ

How many employees does Supernus Pharmaceuticals have?

Supernus Pharmaceuticals has about 686 employees, up 2.2% over the 3 months to Jun 2025.

What is Supernus Pharmaceuticals's revenue per employee?

Supernus Pharmaceuticals makes about $974K in revenue per employee, based on $668M annual revenue and 686 employees.

How much does Supernus Pharmaceuticals pay?

6figr has 1 salary profile for Supernus Pharmaceuticals in the US, with pay broken down by role, level, gender and ethnicity on the Supernus Pharmaceuticals salaries page. See Supernus Pharmaceuticals salaries

Is Supernus Pharmaceuticals a public company?

Yes. Supernus Pharmaceuticals is publicly traded under the ticker SUPN on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.